B · Normal
[CRO concept rebounded in shock, Optima rose by more than 10%] On September 8th, the CRO concept rebounded in the afternoon, with Optima rising by more than 10%, followed by Biocytogen, Nearshore Protein, Wanbang Pharmaceuticals, Hongbo Pharmaceuticals, Haoyuan Pharmaceuticals, Aileen, etc. According to the news, Istevir Hydrochloride Tablets, an innovative drug jointly developed by West Lake University, West Lake Laboratory, and West Lake Pharmaceutical (Hangzhou) Co., Ltd., has been officially approved for marketing by the National Medical Products Administration with conditions. Epresvir is the first domestic original drug approved for marketing with the help of artificial intelligence (AI)-assisted research and development.
Comments